Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04058665 · ClinicalTrials.gov registry record
Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 300
- Enrollment target
NCT04058665: Completed study, sponsored by Johns Hopkins University.
NCT04058665 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04058665 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Perioperative variables that can be used to create a bundled approach quality improvement protocol to minimize blood loss in spine surgery will be evaluated using retrospective data collection and multivariate analysis of previously performed spinal surgeries at Johns Hopkins Hospital. In particular the investigators are interested in determining whether FloSeal® contributes towards increased control over perioperative bleeding compared to other hemostatic agents for potential inclusion in a future bundled approach.
Interventions
- DEVICE Floseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04058665
The ClinicalTrials.gov registry entry for NCT04058665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Floseal is the first listed.
NCT04058665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04058665 about?
NCT04058665 is a clinical study titled "Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery". Perioperative variables that can be used to create a bundled approach quality improvement protocol to minimize blood loss in spine surgery will be evaluated using retrospective data collection and multivariate analysis of previously performed spinal surgeries at Johns Hopkins Hospital. In particular...
What is the current status of trial NCT04058665?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2019-06-18. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT04058665?
The interventions under investigation include: Floseal (DEVICE).
Who is sponsoring clinical trial NCT04058665?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.